Autism Spectrum Disorders and Health Care Expenditures: The Effects of Co-Occurring Conditions
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Children with autism spectrum disorders (ASDs) often have co-occurring conditions, but little is known on the effect of those conditions on their medical care cost. Medical expenditures attributable to ASDs among Medicaid-enrolled children were calculated, and the effects of 3 commonly co-occurring conditions--intellectual disability (ID), attention deficit/hyperactivity disorder (ADHD), and epilepsy-on those expenditures were analyzed. METHODS: Using MarketScan Medicaid Multi-State Databases (2003-2005) and the International Classification of Disease, Ninth Revision, children with ASD were identified. Children without ASD formed the comparison group. The 3 co-occurring conditions were identified among both the ASD and the comparison groups. Annual mean, median, and 95th percentile of total expenditures were calculated for children with ASD and the co-occurring conditions and compared with those of children without ASD. Multivariate analyses established the influence of each of those co-occurring conditions on the average expenditures for children with and without ASD. RESULTS: In 2005, 47% of children with ASD had at least 1 selected co-occurring condition; attention deficit/hyperactivity disorder was the most common, at 30%. The mean medical expenditures for children with ASD were 6 times higher than those of the comparison group. Children with ASD and ID incurred expenditures 2.7 times higher than did children with ASD and no co-occurring condition. CONCLUSION: Medicaid-enrolled children with ASD incurred higher medical costs than did Medicaid-enrolled children without ASD. Among Medicaid-enrolled children with ASD, cost varied substantially based on the presence of another neurodevelopmental disorder. In particular, children with ID had much higher costs than did other children with ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, S. E., Giarelli, E., Lee, L.-C., Schieve, L. A., Kirby, R. S., Cunniff, C., Nicholas, J., Reaven, J., & Rice, C. E. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5d03b · Cited by 504
Cited by
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
Economic Burden of Childhood Autism Spectrum Disorders
Lavelle, T. A., Weinstein, M. C., Newhouse, J. P., Munir, K., Kuhlthau, K. A., & Prosser, L. A. (2014) · Pediatrics · doi:10.1542/peds.2013-0763 · Cited by 489
Parental Concerns, Provider Response, and Timeliness of Autism Spectrum Disorder Diagnosis
Zuckerman, K. E., Lindly, O. J., & Sinche, B. K. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.03.007 · Cited by 215
“Because the lifetime cost of treating an individual with ASD exceeds $1 million in the US, efforts to identify promptly and treat ASD symptoms and comorbidities also may affect long-term costs.(11-13) Unfortunately, however, many children with ASD are not diagnosed until school age,(14-17) and poor, minority, and less…”
BackgroundSoke, G. N., Maenner, M. J., Christensen, D., Kurzius-Spencer, M., & Schieve, L. A. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3521-1 · Cited by 194
“Co-occurring conditions/symptoms increase the societal impact of ASD, since they often contribute to a higher level of impairment, increased need for services, including medications and emergency rooms visits for injuries, impacting the quality of life of children with ASD and their families (Gurney et al. 2006; Ianuz…”
Vohra, R., Madhavan, S., & Sambamoorthi, U. (2017) · Autism · doi:10.1177/1362361316665222 · Cited by 174
“…associated with higher medication use (Buck et al., 2014; Mandell, 2008; Mandell et al., 2008), greater hospitalization rates, higher expenditures (Peacock et al., 2012), and extremely high lifetime support costs per individual with ASD (ASD = US$1.4 million and ASD + intellectual disability =…”
Influential
Metadata
- Authors
- Peacock, G., Amendah, D., Ouyang, L., & Grosse, S. D.
- Venue
- Journal of Developmental & Behavioral Pediatrics
- Published
- 2012-01
- Volume
- 33
- Issue
- 1
- Pages
- 2-8
- ISSN
- 0196-206X (ISSN-L)
- OpenAlex
- W2055301101
- Cited by
- 133
- References
- 1
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.